Research progress in molecular pathology markers in medulloblastoma

• Glavni autori: Zixuan Zhou (Autor), Bingxin Zhu (Autor), Qingming Meng (Autor), Tong Zhang (Autor), Yihao Wu (Autor), Rutong Yu (Autor), Shangfeng Gao (Autor)
• Format: Knjiga
• Izdano: Open Exploration Publishing Inc., 2023-02-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Medulloblastoma (MB) is the commonest primary malignant brain cancer. The current treatment of MB is usually surgical resection combined with radiotherapy or chemotherapy. Although great progress has been made in the clinical management of MB, tumor metastasis and recurrence are still the main cause...